Fibrodysplasia ossificans progressiva.

Area of Science:

• Genetics
• Connective Tissue Disorders
• Rare Diseases

Background:

• Fibrodysplasia ossificans progressiva (FOP) is an extremely rare genetic disorder.
• It causes progressive heterotopic ossification in connective tissues, leading to severe disability.
• FOP affects approximately 1 in 2 million people, with congenital great toe malformation as a hallmark.

Purpose of the Study:

• To summarize the key characteristics of Fibrodysplasia ossificans progressiva.
• To highlight the current understanding of its pathophysiology and genetic basis.
• To underscore the urgent need for effective treatments for FOP patients.

Main Methods:

• Literature review of Fibrodysplasia ossificans progressiva.
• Analysis of epidemiological data and clinical presentation.
• Review of recent discoveries in FOP pathophysiology and genetics.

Main Results:

• FOP is a dominant genetic trait with variable expression, affecting connective tissues and leading to progressive ossification.
• Patients often experience severe disability, requiring wheelchairs by the third decade and facing pulmonary complications.
• Overproduction of bone morphogenetic protein-4 in lesional cells is implicated in FOP.
• The FOP gene has been mapped to human chromosome 4q 27-31.

Conclusions:

• Fibrodysplasia ossificans progressiva is a devastating genetic disorder with no current effective treatment or prevention.
• Understanding the role of bone morphogenetic protein-4 offers potential therapeutic avenues.
• Genetic mapping provides a foundation for future research into FOP.